Evidence map›Paper›PMID 27166760›Full record

ArticleMolecular psychiatry2017

CNTN6 mutations are risk factors for abnormal auditory sensory perception in autism spectrum disorders.

O Mercati, G Huguet, A Danckaert, G André-Leroux, A Maruani, M Bellinzoni, T Rolland, L Gouder, A Mathieu, J Buratti and 26 more

Open access · hybridAbstract read
In one paragraph

Article in Molecular psychiatry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Molecular mechanism of contactin 2 homophilic interaction.Structure (London, England : 1993) · 2024
    Article
  13. Loss of primary cilia and dopaminergic neuroprotection in pathogenic LRRK2-driven and idiopathic Parkinson's disease.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Proteomic characterization of atopic dermatitis blood from infancy to adulthood.Journal of the American Academy of Dermatology · 2023
    Observational
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors at 12 institutions in 4 countries.

O MercatiHuman Genetics and Cognitive Functions Unit, Institut Pasteur, Paris, France.
G HuguetHuman Genetics and Cognitive Functions Unit, Institut Pasteur, Paris, France.
A DanckaertImagopole, Citech, Institut Pasteur, Paris, France.
G André-LerouxInstitut Pasteur, Unité de Microbiologie Structurale, Paris, France.
A MaruaniAssistance Publique-Hôpitaux de Paris, Child and Adolescent Psychiatry Department, Robert Debré Hospital, Paris, France.
M BellinzoniInstitut Pasteur, Unité de Microbiologie Structurale, Paris, France.
T RollandHuman Genetics and Cognitive Functions Unit, Institut Pasteur, Paris, France.
L GouderHuman Genetics and Cognitive Functions Unit, Institut Pasteur, Paris, France.
A MathieuHuman Genetics and Cognitive Functions Unit, Institut Pasteur, Paris, France.
J BurattiHuman Genetics and Cognitive Functions Unit, Institut Pasteur, Paris, France.
F AmsellemAssistance Publique-Hôpitaux de Paris, Child and Adolescent Psychiatry Department, Robert Debré Hospital, Paris, France.
M BenabouHuman Genetics and Cognitive Functions Unit, Institut Pasteur, Paris, France.
J Van-GilsHuman Genetics and Cognitive Functions Unit, Institut Pasteur, Paris, France.
A BeggiatoAssistance Publique-Hôpitaux de Paris, Child and Adolescent Psychiatry Department, Robert Debré Hospital, Paris, France.
M KonyukhHuman Genetics and Cognitive Functions Unit, Institut Pasteur, Paris, France.
J-P BourgeoisHuman Genetics and Cognitive Functions Unit, Institut Pasteur, Paris, France.
M J GazzelloneCentre for Applied Genomics, Program in Genetics and Genome Biology, Hospital for Sick Children, Toronto, ON, Canada.
R K C YuenCentre for Applied Genomics, Program in Genetics and Genome Biology, Hospital for Sick Children, Toronto, ON, Canada.
S WalkerCentre for Applied Genomics, Program in Genetics and Genome Biology, Hospital for Sick Children, Toronto, ON, Canada.
M DelépineCentre National de Génotypage, Evry, France.
A BolandCentre National de Génotypage, Evry, France.
B RégnaultEukaryote Genotyping Platform, Genopole, Institut Pasteur, Paris, France.
M FrancoisAssistance Publique-Hôpitaux de Paris, ENT and Head and Neck Surgery Department, Robert Debré Hospital, Paris-VII University, Paris, France.
T Van Den AbbeeleAssistance Publique-Hôpitaux de Paris, ENT and Head and Neck Surgery Department, Robert Debré Hospital, Paris-VII University, Paris, France.
A L Mosca-BoidronDépartement de Génétique, CHU Dijon et Université de Bourgogne, Dijon, France.
L FaivreDépartement de Génétique, CHU Dijon et Université de Bourgogne, Dijon, France.
Y ShimodaDepartment of Bioengineering, Nagaoka University of Technology, Nagaoka, Japan.ORCID 0000-0001-9230-6784
K WatanabeDepartment of Bioengineering, Nagaoka University of Technology, Nagaoka, Japan.
D BonneauDépartement de Biochimie et Génétique, Centre Hospitalier Universitaire, Angers, France.
M RastamDepartment of Clinical Sciences in Lund, Lund University, Lund, Sweden.
M LeboyerINSERM U955, Psychiatrie Translationnelle, Créteil, France.
S W SchererCentre for Applied Genomics, Program in Genetics and Genome Biology, Hospital for Sick Children, Toronto, ON, Canada.
C GillbergGillberg Neuropsychiatry Centre, University of Gothenburg, Gothenburg, Sweden.
R DelormeHuman Genetics and Cognitive Functions Unit, Institut Pasteur, Paris, France.
I Cloëz-TayaraniHuman Genetics and Cognitive Functions Unit, Institut Pasteur, Paris, France.
T BourgeronHuman Genetics and Cognitive Functions Unit, Institut Pasteur, Paris, France.
Centre National de la Recherche Scientifique · FRAssistance Publique – Hôpitaux de Paris · FRHospital for Sick Children · CACentre National de Recherche en Génomique Humaine · FRInstitut Pasteur · FRNagaoka University of Technology · JPUniversité de Bourgogne · FRCentre Hospitalier Universitaire d'Angers · FRInserm · FRLund University · SEUniversity of Gothenburg · SEUniversity of Toronto · CA

Funding

The Collaborative Genetic Study of Nicotine DependenceP01CA089392 · NCI · WASHINGTON UNIVERSITY · PI BIERUT, LAURA J. · 2001 to 2012
$17.3M
RELAPSE: LINKING SCIENCE AND PRACTICEP50CA084724 · NCI · UNIVERSITY OF WISCONSIN MADISON · PI FIORE, MICHAEL C · 1999 to 2003
$8.9M
Tobacco Dependence: Treatment and OutcomesP50DA019706 · NIDA · UNIVERSITY OF WISCONSIN-MADISON · PI JACKSON, THOMAS C · 2004 to 2008
$8.6M
Genome Wide Association Coordinating CenterU01HG004446 · NHGRI · UNIVERSITY OF WASHINGTON · PI WEIR, BRUCE S. · 2007 to 2011
$6.6M
NCI NIH HHS P01 CA089392NCI NIH HHS P50 CA084724NHGRI NIH HHS U01 HG004446NIDA NIH HHS P50 DA019706
6 · The paper itself

Abstract

Contactin genes CNTN5 and CNTN6 code for neuronal cell adhesion molecules that promote neurite outgrowth in sensory-motor neuronal pathways. Mutations of CNTN5 and CNTN6 have previously been reported in individuals with autism spectrum disorders (ASDs), but very little is known on their prevalence and clinical impact. In this study, we identified CNTN5 and CNTN6 deleterious variants in individuals with ASD. Among the carriers, a girl with ASD and attention-deficit/hyperactivity disorder was carrying five copies of CNTN5. For CNTN6, both deletions (6/1534 ASD vs 1/8936 controls; P=0.00006) and private coding sequence variants (18/501 ASD vs 535/33480 controls; P=0.0005) were enriched in individuals with ASD. Among the rare CNTN6 variants, two deletions were transmitted by fathers diagnosed with ASD, one stop mutation CNTN6

Indexed as

AdolescentAdultAttention Deficit Disorder with HyperactivityAuditory PerceptionAutism Spectrum DisorderChildContactinsDNA Copy Number VariationsFemaleGenetic Predisposition to DiseaseHumansMaleMutationPolymorphism, Single NucleotideCNTN5 protein, humanCNTN6 protein, humanContactins

Identifiers

PMID27166760
PMCPMC5378808
OpenAlexW2355214356

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.